ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cancer Biomarker Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-5B8063
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Cancer Biomarker Market Insights and Forecast to 2028
BUY CHAPTERS

Global Cancer Biomarker Market Research Report 2025

Code: QYRE-Auto-5B8063
Report
August 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Thermo Fisher Scientific
Bio Rad Laboratories
Roche Diagnostics
Qiagen NV
Illumina Inc
GE Healthcare
Agilent Technologies
BioMérieux SA
Merck
Abbott Laboratories
Becton Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic Inc
Quest Diagnostics

Cancer Biomarker Market Size

The global market for Cancer Biomarker was valued at US$ 24350 million in the year 2024 and is projected to reach a revised size of US$ 51250 million by 2031, growing at a CAGR of 11.4% during the forecast period.

Cancer Biomarker Market

Cancer Biomarker Market

Cancer biomarkers are substances or processes that are indicative of the presence of cancers in the human body. Biomarkers may be produced by the cancer tissue itself or by other cells in the body in response to cancer. They can be found in the blood, stool, urine, tumor tissue, or other tissues or bodily fluids.
North American market for Cancer Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Biomarker is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Cancer Biomarker include Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomérieux SA, Merck & Co., Abbott Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cancer Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Biomarker.
The Cancer Biomarker market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Biomarker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cancer Biomarker Market Report

Report Metric Details
Report Name Cancer Biomarker Market
Accounted market size in year US$ 24350 million
Forecasted market size in 2031 US$ 51250 million
CAGR 11.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Diagnostics
  • Research
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomérieux SA, Merck & Co., Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Myriad Genetics, Sysmex Corporation, Hologic, Quest Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cancer Biomarker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cancer Biomarker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Cancer Biomarker Market growing?

Ans: The Cancer Biomarker Market witnessing a CAGR of 11.4% during the forecast period 2025-2031.

What is the Cancer Biomarker Market size in 2031?

Ans: The Cancer Biomarker Market size in 2031 will be US$ 51250 million.

Who are the main players in the Cancer Biomarker Market report?

Ans: The main players in the Cancer Biomarker Market are Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen, Illumina, GE Healthcare, Agilent Technologies, Biomérieux SA, Merck & Co., Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Myriad Genetics, Sysmex Corporation, Hologic, Quest Diagnostics

What are the Application segmentation covered in the Cancer Biomarker Market report?

Ans: The Applications covered in the Cancer Biomarker Market report are Diagnostics, Research, Others

What are the Type segmentation covered in the Cancer Biomarker Market report?

Ans: The Types covered in the Cancer Biomarker Market report are Protein Biomarker, Genetic Biomarker

Recommended Reports

Cancer Diagnostics

Biomarker Technologies

Genomic & Precision

1 Cancer Biomarker Market Overview
1.1 Product Definition
1.2 Cancer Biomarker by Type
1.2.1 Global Cancer Biomarker Market Value Comparison by Type (2024 VS 2031)
1.2.2 Protein Biomarker
1.2.3 Genetic Biomarker
1.3 Cancer Biomarker by Application
1.3.1 Global Cancer Biomarker Market Value by Application (2024 VS 2031)
1.3.2 Diagnostics
1.3.3 Research
1.3.4 Others
1.4 Global Cancer Biomarker Market Size Estimates and Forecasts
1.4.1 Global Cancer Biomarker Revenue 2020-2031
1.4.2 Global Cancer Biomarker Sales 2020-2031
1.4.3 Global Cancer Biomarker Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cancer Biomarker Market Competition by Manufacturers
2.1 Global Cancer Biomarker Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cancer Biomarker Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cancer Biomarker Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cancer Biomarker, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cancer Biomarker, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cancer Biomarker, Product Type & Application
2.7 Global Key Manufacturers of Cancer Biomarker, Date of Enter into This Industry
2.8 Global Cancer Biomarker Market Competitive Situation and Trends
2.8.1 Global Cancer Biomarker Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cancer Biomarker Players Market Share by Revenue
2.8.3 Global Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cancer Biomarker Market Scenario by Region
3.1 Global Cancer Biomarker Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cancer Biomarker Sales by Region: 2020-2031
3.2.1 Global Cancer Biomarker Sales by Region: 2020-2025
3.2.2 Global Cancer Biomarker Sales by Region: 2026-2031
3.3 Global Cancer Biomarker Revenue by Region: 2020-2031
3.3.1 Global Cancer Biomarker Revenue by Region: 2020-2025
3.3.2 Global Cancer Biomarker Revenue by Region: 2026-2031
3.4 North America Cancer Biomarker Market Facts & Figures by Country
3.4.1 North America Cancer Biomarker Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cancer Biomarker Sales by Country (2020-2031)
3.4.3 North America Cancer Biomarker Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cancer Biomarker Market Facts & Figures by Country
3.5.1 Europe Cancer Biomarker Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cancer Biomarker Sales by Country (2020-2031)
3.5.3 Europe Cancer Biomarker Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cancer Biomarker Market Facts & Figures by Region
3.6.1 Asia Pacific Cancer Biomarker Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cancer Biomarker Sales by Region (2020-2031)
3.6.3 Asia Pacific Cancer Biomarker Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cancer Biomarker Market Facts & Figures by Country
3.7.1 Latin America Cancer Biomarker Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cancer Biomarker Sales by Country (2020-2031)
3.7.3 Latin America Cancer Biomarker Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cancer Biomarker Market Facts & Figures by Country
3.8.1 Middle East and Africa Cancer Biomarker Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cancer Biomarker Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cancer Biomarker Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cancer Biomarker Sales by Type (2020-2031)
4.1.1 Global Cancer Biomarker Sales by Type (2020-2025)
4.1.2 Global Cancer Biomarker Sales by Type (2026-2031)
4.1.3 Global Cancer Biomarker Sales Market Share by Type (2020-2031)
4.2 Global Cancer Biomarker Revenue by Type (2020-2031)
4.2.1 Global Cancer Biomarker Revenue by Type (2020-2025)
4.2.2 Global Cancer Biomarker Revenue by Type (2026-2031)
4.2.3 Global Cancer Biomarker Revenue Market Share by Type (2020-2031)
4.3 Global Cancer Biomarker Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cancer Biomarker Sales by Application (2020-2031)
5.1.1 Global Cancer Biomarker Sales by Application (2020-2025)
5.1.2 Global Cancer Biomarker Sales by Application (2026-2031)
5.1.3 Global Cancer Biomarker Sales Market Share by Application (2020-2031)
5.2 Global Cancer Biomarker Revenue by Application (2020-2031)
5.2.1 Global Cancer Biomarker Revenue by Application (2020-2025)
5.2.2 Global Cancer Biomarker Revenue by Application (2026-2031)
5.2.3 Global Cancer Biomarker Revenue Market Share by Application (2020-2031)
5.3 Global Cancer Biomarker Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Scientific Cancer Biomarker Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Bio-Rad Laboratories
6.2.1 Bio-Rad Laboratories Company Information
6.2.2 Bio-Rad Laboratories Description and Business Overview
6.2.3 Bio-Rad Laboratories Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bio-Rad Laboratories Cancer Biomarker Product Portfolio
6.2.5 Bio-Rad Laboratories Recent Developments/Updates
6.3 Roche Diagnostics
6.3.1 Roche Diagnostics Company Information
6.3.2 Roche Diagnostics Description and Business Overview
6.3.3 Roche Diagnostics Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Diagnostics Cancer Biomarker Product Portfolio
6.3.5 Roche Diagnostics Recent Developments/Updates
6.4 Qiagen
6.4.1 Qiagen Company Information
6.4.2 Qiagen Description and Business Overview
6.4.3 Qiagen Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Qiagen Cancer Biomarker Product Portfolio
6.4.5 Qiagen Recent Developments/Updates
6.5 Illumina
6.5.1 Illumina Company Information
6.5.2 Illumina Description and Business Overview
6.5.3 Illumina Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Illumina Cancer Biomarker Product Portfolio
6.5.5 Illumina Recent Developments/Updates
6.6 GE Healthcare
6.6.1 GE Healthcare Company Information
6.6.2 GE Healthcare Description and Business Overview
6.6.3 GE Healthcare Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GE Healthcare Cancer Biomarker Product Portfolio
6.6.5 GE Healthcare Recent Developments/Updates
6.7 Agilent Technologies
6.7.1 Agilent Technologies Company Information
6.7.2 Agilent Technologies Description and Business Overview
6.7.3 Agilent Technologies Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Agilent Technologies Cancer Biomarker Product Portfolio
6.7.5 Agilent Technologies Recent Developments/Updates
6.8 Biomérieux SA
6.8.1 Biomérieux SA Company Information
6.8.2 Biomérieux SA Description and Business Overview
6.8.3 Biomérieux SA Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Biomérieux SA Cancer Biomarker Product Portfolio
6.8.5 Biomérieux SA Recent Developments/Updates
6.9 Merck & Co.
6.9.1 Merck & Co. Company Information
6.9.2 Merck & Co. Description and Business Overview
6.9.3 Merck & Co. Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck & Co. Cancer Biomarker Product Portfolio
6.9.5 Merck & Co. Recent Developments/Updates
6.10 Abbott Laboratories
6.10.1 Abbott Laboratories Company Information
6.10.2 Abbott Laboratories Description and Business Overview
6.10.3 Abbott Laboratories Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Abbott Laboratories Cancer Biomarker Product Portfolio
6.10.5 Abbott Laboratories Recent Developments/Updates
6.11 Becton, Dickinson and Company
6.11.1 Becton, Dickinson and Company Company Information
6.11.2 Becton, Dickinson and Company Description and Business Overview
6.11.3 Becton, Dickinson and Company Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Becton, Dickinson and Company Cancer Biomarker Product Portfolio
6.11.5 Becton, Dickinson and Company Recent Developments/Updates
6.12 Danaher Corporation
6.12.1 Danaher Corporation Company Information
6.12.2 Danaher Corporation Description and Business Overview
6.12.3 Danaher Corporation Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Danaher Corporation Cancer Biomarker Product Portfolio
6.12.5 Danaher Corporation Recent Developments/Updates
6.13 Myriad Genetics
6.13.1 Myriad Genetics Company Information
6.13.2 Myriad Genetics Description and Business Overview
6.13.3 Myriad Genetics Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Myriad Genetics Cancer Biomarker Product Portfolio
6.13.5 Myriad Genetics Recent Developments/Updates
6.14 Sysmex Corporation
6.14.1 Sysmex Corporation Company Information
6.14.2 Sysmex Corporation Description and Business Overview
6.14.3 Sysmex Corporation Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sysmex Corporation Cancer Biomarker Product Portfolio
6.14.5 Sysmex Corporation Recent Developments/Updates
6.15 Hologic
6.15.1 Hologic Company Information
6.15.2 Hologic Description and Business Overview
6.15.3 Hologic Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Hologic Cancer Biomarker Product Portfolio
6.15.5 Hologic Recent Developments/Updates
6.16 Quest Diagnostics
6.16.1 Quest Diagnostics Company Information
6.16.2 Quest Diagnostics Description and Business Overview
6.16.3 Quest Diagnostics Cancer Biomarker Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Quest Diagnostics Cancer Biomarker Product Portfolio
6.16.5 Quest Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cancer Biomarker Industry Chain Analysis
7.2 Cancer Biomarker Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cancer Biomarker Production Mode & Process Analysis
7.4 Cancer Biomarker Sales and Marketing
7.4.1 Cancer Biomarker Sales Channels
7.4.2 Cancer Biomarker Distributors
7.5 Cancer Biomarker Customer Analysis
8 Cancer Biomarker Market Dynamics
8.1 Cancer Biomarker Industry Trends
8.2 Cancer Biomarker Market Drivers
8.3 Cancer Biomarker Market Challenges
8.4 Cancer Biomarker Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Thermo Fisher Scientific
Bio Rad Laboratories
Roche Diagnostics
Qiagen NV
Illumina Inc
GE Healthcare
Agilent Technologies
BioMérieux SA
Merck
Abbott Laboratories
Becton Dickinson and Company
Danaher Corporation
Myriad Genetics
Sysmex Corporation
Hologic Inc
Quest Diagnostics
List of Tables
 Table 1. Global Cancer Biomarker Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cancer Biomarker Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cancer Biomarker Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cancer Biomarker Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cancer Biomarker Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cancer Biomarker Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cancer Biomarker Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cancer Biomarker Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cancer Biomarker, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cancer Biomarker, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cancer Biomarker, Product Type & Application
 Table 12. Global Key Manufacturers of Cancer Biomarker, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cancer Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Biomarker as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cancer Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cancer Biomarker Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cancer Biomarker Sales Market Share by Region (2020-2025)
 Table 19. Global Cancer Biomarker Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cancer Biomarker Sales Market Share by Region (2026-2031)
 Table 21. Global Cancer Biomarker Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cancer Biomarker Revenue Market Share by Region (2020-2025)
 Table 23. Global Cancer Biomarker Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cancer Biomarker Revenue Market Share by Region (2026-2031)
 Table 25. North America Cancer Biomarker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cancer Biomarker Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cancer Biomarker Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cancer Biomarker Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cancer Biomarker Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cancer Biomarker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cancer Biomarker Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cancer Biomarker Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cancer Biomarker Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cancer Biomarker Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cancer Biomarker Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cancer Biomarker Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cancer Biomarker Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cancer Biomarker Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cancer Biomarker Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cancer Biomarker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cancer Biomarker Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cancer Biomarker Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cancer Biomarker Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cancer Biomarker Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cancer Biomarker Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cancer Biomarker Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cancer Biomarker Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cancer Biomarker Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cancer Biomarker Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cancer Biomarker Sales (K Units) by Type (2020-2025)
 Table 51. Global Cancer Biomarker Sales (K Units) by Type (2026-2031)
 Table 52. Global Cancer Biomarker Sales Market Share by Type (2020-2025)
 Table 53. Global Cancer Biomarker Sales Market Share by Type (2026-2031)
 Table 54. Global Cancer Biomarker Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cancer Biomarker Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cancer Biomarker Revenue Market Share by Type (2020-2025)
 Table 57. Global Cancer Biomarker Revenue Market Share by Type (2026-2031)
 Table 58. Global Cancer Biomarker Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Cancer Biomarker Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Cancer Biomarker Sales (K Units) by Application (2020-2025)
 Table 61. Global Cancer Biomarker Sales (K Units) by Application (2026-2031)
 Table 62. Global Cancer Biomarker Sales Market Share by Application (2020-2025)
 Table 63. Global Cancer Biomarker Sales Market Share by Application (2026-2031)
 Table 64. Global Cancer Biomarker Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cancer Biomarker Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cancer Biomarker Revenue Market Share by Application (2020-2025)
 Table 67. Global Cancer Biomarker Revenue Market Share by Application (2026-2031)
 Table 68. Global Cancer Biomarker Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Cancer Biomarker Price (USD/Unit) by Application (2026-2031)
 Table 70. Thermo Fisher Scientific Company Information
 Table 71. Thermo Fisher Scientific Description and Business Overview
 Table 72. Thermo Fisher Scientific Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Thermo Fisher Scientific Cancer Biomarker Product
 Table 74. Thermo Fisher Scientific Recent Developments/Updates
 Table 75. Bio-Rad Laboratories Company Information
 Table 76. Bio-Rad Laboratories Description and Business Overview
 Table 77. Bio-Rad Laboratories Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Bio-Rad Laboratories Cancer Biomarker Product
 Table 79. Bio-Rad Laboratories Recent Developments/Updates
 Table 80. Roche Diagnostics Company Information
 Table 81. Roche Diagnostics Description and Business Overview
 Table 82. Roche Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Roche Diagnostics Cancer Biomarker Product
 Table 84. Roche Diagnostics Recent Developments/Updates
 Table 85. Qiagen Company Information
 Table 86. Qiagen Description and Business Overview
 Table 87. Qiagen Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. Qiagen Cancer Biomarker Product
 Table 89. Qiagen Recent Developments/Updates
 Table 90. Illumina Company Information
 Table 91. Illumina Description and Business Overview
 Table 92. Illumina Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Illumina Cancer Biomarker Product
 Table 94. Illumina Recent Developments/Updates
 Table 95. GE Healthcare Company Information
 Table 96. GE Healthcare Description and Business Overview
 Table 97. GE Healthcare Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. GE Healthcare Cancer Biomarker Product
 Table 99. GE Healthcare Recent Developments/Updates
 Table 100. Agilent Technologies Company Information
 Table 101. Agilent Technologies Description and Business Overview
 Table 102. Agilent Technologies Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Agilent Technologies Cancer Biomarker Product
 Table 104. Agilent Technologies Recent Developments/Updates
 Table 105. Biomérieux SA Company Information
 Table 106. Biomérieux SA Description and Business Overview
 Table 107. Biomérieux SA Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Biomérieux SA Cancer Biomarker Product
 Table 109. Biomérieux SA Recent Developments/Updates
 Table 110. Merck & Co. Company Information
 Table 111. Merck & Co. Description and Business Overview
 Table 112. Merck & Co. Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Merck & Co. Cancer Biomarker Product
 Table 114. Merck & Co. Recent Developments/Updates
 Table 115. Abbott Laboratories Company Information
 Table 116. Abbott Laboratories Description and Business Overview
 Table 117. Abbott Laboratories Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Abbott Laboratories Cancer Biomarker Product
 Table 119. Abbott Laboratories Recent Developments/Updates
 Table 120. Becton, Dickinson and Company Company Information
 Table 121. Becton, Dickinson and Company Description and Business Overview
 Table 122. Becton, Dickinson and Company Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Becton, Dickinson and Company Cancer Biomarker Product
 Table 124. Becton, Dickinson and Company Recent Developments/Updates
 Table 125. Danaher Corporation Company Information
 Table 126. Danaher Corporation Description and Business Overview
 Table 127. Danaher Corporation Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Danaher Corporation Cancer Biomarker Product
 Table 129. Danaher Corporation Recent Developments/Updates
 Table 130. Myriad Genetics Company Information
 Table 131. Myriad Genetics Description and Business Overview
 Table 132. Myriad Genetics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. Myriad Genetics Cancer Biomarker Product
 Table 134. Myriad Genetics Recent Developments/Updates
 Table 135. Sysmex Corporation Company Information
 Table 136. Sysmex Corporation Description and Business Overview
 Table 137. Sysmex Corporation Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Sysmex Corporation Cancer Biomarker Product
 Table 139. Sysmex Corporation Recent Developments/Updates
 Table 140. Hologic Company Information
 Table 141. Hologic Description and Business Overview
 Table 142. Hologic Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Hologic Cancer Biomarker Product
 Table 144. Hologic Recent Developments/Updates
 Table 145. Quest Diagnostics Company Information
 Table 146. Quest Diagnostics Description and Business Overview
 Table 147. Quest Diagnostics Cancer Biomarker Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Quest Diagnostics Cancer Biomarker Product
 Table 149. Quest Diagnostics Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Cancer Biomarker Distributors List
 Table 153. Cancer Biomarker Customers List
 Table 154. Cancer Biomarker Market Trends
 Table 155. Cancer Biomarker Market Drivers
 Table 156. Cancer Biomarker Market Challenges
 Table 157. Cancer Biomarker Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cancer Biomarker
 Figure 2. Global Cancer Biomarker Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cancer Biomarker Market Share by Type: 2024 & 2031
 Figure 4. Protein Biomarker Product Picture
 Figure 5. Genetic Biomarker Product Picture
 Figure 6. Global Cancer Biomarker Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cancer Biomarker Market Share by Application: 2024 & 2031
 Figure 8. Diagnostics
 Figure 9. Research
 Figure 10. Others
 Figure 11. Global Cancer Biomarker Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Cancer Biomarker Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Cancer Biomarker Sales (2020-2031) & (K Units)
 Figure 14. Global Cancer Biomarker Average Price (USD/Unit) & (2020-2031)
 Figure 15. Cancer Biomarker Report Years Considered
 Figure 16. Cancer Biomarker Sales Share by Manufacturers in 2024
 Figure 17. Global Cancer Biomarker Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Cancer Biomarker Players: Market Share by Revenue in Cancer Biomarker in 2024
 Figure 19. Cancer Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Cancer Biomarker Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Cancer Biomarker Sales Market Share by Country (2020-2031)
 Figure 22. North America Cancer Biomarker Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Cancer Biomarker Sales Market Share by Country (2020-2031)
 Figure 26. Europe Cancer Biomarker Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Cancer Biomarker Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Cancer Biomarker Revenue Market Share by Region (2020-2031)
 Figure 34. China Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Cancer Biomarker Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Cancer Biomarker Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Cancer Biomarker Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Cancer Biomarker Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Cancer Biomarker Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Cancer Biomarker by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Cancer Biomarker by Type (2020-2031)
 Figure 56. Global Cancer Biomarker Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Cancer Biomarker by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Cancer Biomarker by Application (2020-2031)
 Figure 59. Global Cancer Biomarker Price (USD/Unit) by Application (2020-2031)
 Figure 60. Cancer Biomarker Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Oncology Biomarker Market Insights Forecast to 2030
Global Cancer Molecular Biomarkers Market Research Report 2024
Global Cancer Biomarkers Detection Market Research Report 2024
Global Biomarker Testing for Cancer Market Research Report 2024
Global Commercializing Biomarkers Market Research Report 2025
Global Tumor Marker Test Kits Market Research Report 2025
Global Cancer Antigen Market Research Report 2024
Global Noninvasive Cancer Biomarkers Market Research Report 2024
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Insights Forecast to 2030
Biomarker Analysis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Biomarker Market Research Report 2024
Proteomic Biomarker Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tumor Marker Detection Market Research Report 2025
Global Clinical Biomarkers Market Research Report 2024
Global Alpha Fetoprotein AFP Tumor Marker Test Reagents Market Research Report 2024
Global Prostate Specific Antigen PSA Biomarker Market Insights Forecast to 2030
Global Liquid Biopsy For Cancer Diagnostics Market Research Report 2024
Global Biomarker Detection Systems Market Research Report 2024
Global Brain Biomarker Market Research Report 2024
Global Cardiac Biomarkers Testing Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions